Boehringer Ingelheim | Atrovent (Medication)
Atrovent is indicated as a bronchodilator in the treatment of bronchospasm in COPD, chronic bronchitis and emphysema. Atrovent is indicated in combination with inhaled beta-agonist treatment of acute bronchospasm in chronic bronchitis and asthma.
Atrovent is a pressurized metered-dose aerosol unit for oral inhalation that contains a solution of ipratropium bromide. ...
The most commonly observed adverse reactions are headache, nausea and dry mouth. Due to low systemic absorption of Atrovent/ipratropium bromide, unwanted anticholinergic effects as tachycardia and palpitations, visual accommodation disturbances, gastrointestinal motility disturbances and urinary retention are rare and reversible, although there is an increased risk of urinary retention in patients with preexisting obstruction urinary tract. ...
Prior to using Atrovent, inform your healthcare provider if you have any type of allergies. Tell your doctor if you have:narrow-angle glaucoma; or an enlarged prostate or a bladder obstruction.
This drug may make you dizzy or cause blurred vision or other vision changes. Avoid driving, using machinery, or doing any activity that requires alertness or clear vision until you are sure you can perform such activities safely. Limit alcoholic beverages.
During pregnancy and breastfeeding is not recommended to use this medicine without your doctor's advice. ...